Key facts
- Notable investors include Changchun Huize Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cypo Biotech (Changchun)
- ·The full record, as it builds
Funding rounds
No funding rounds for Cypo Biotech (Changchun) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cypo Biotech (Changchun)
Provider of biotechnological research services intended for scientific investigation and healthcare development purposes. The company offers cell culture systems, protein characterization technologies, molecular biology reagents, laboratory consumables, and technical support services, enabling pharmaceutical enterprises and healthcare organizations to conduct experimental studies, improve diagnostic development, strengthen therapeutic innovation, and expand reliable access to scalable scientific resources across diverse areas of life sciences and applied medical research.
- Sector
- Healthcare
- HQ
- Changchun, China
- Founded
- 2019
- Employees
- 7
- Ownership
- Privately Held (backing)
Cypo Biotech (Changchun) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cypo Biotech (Changchun) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cypo Biotech (Changchun) in its N-PORT filings yet. We sweep new filings monthly.